Synopsis of recent research by authors named "Amel Khattab"
- Amel Khattab's recent research primarily focuses on the adverse effects of pharmaceutical treatments, particularly concerning respiratory conditions and the implications of antituberculous therapy on kidney health and infectious diseases.
- Notably, findings highlight the potential for valproic acid to induce reversible respiratory events and the risks associated with rifampicin in causing acute tubulointerstitial nephritis among tuberculosis patients.
- Additionally, Khattab investigates the complexities of diagnosing pulmonary infections, exemplified by cases of pulmonary actinomycosis that mimic malignancies and the presentation of tuberculous pericarditis, underscoring the challenges faced in clinical settings.
